• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: October 1-6


ICYMI, this week we had articles about the beginning of National Eczema Awareness Month, OM1's new HS dataset, an interview with the founder and CEO of the Picking Me Foundation, and more.

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

October is Eczema Awareness Month and Dermatology Times is recognizing research to best serve patients with the most common type of eczema, atopic dermatitis.

Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD

Raj Chovatiya, MD, PhD, shares his atopic dermatitis insights.

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

New and emerging therapies to treat a variety of skin conditions were presented by George Martin, MD, and Ted Rosen, MD.

Eczema Resources for Your Patients: Week 1

Prepare your patients with helpful resources each week throughout National Eczema Awareness Month.

FDA Issues Complete Response Letter for Lebrikizumab

No concerns were cited about the clinical data package, safety, or label of lebrikizumab.

Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports

Investigators reported successful treatment of psoriasis with risankizumab, despite presence of concomitant HIV infection in 4 male patients.

Get Ready to Test Your Atopic Dermatitis Knowledge

Check in throughout the month to learn more about the latest treatment pearls and research findings in DermIQ’s spotlight on atopic dermatitis.

A Puzzling Case of Redness in Atopic Dermatitis

A patient with atopic dermatitis presents with redness and other unusual symptoms. What's the diagnosis?

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

Brauer’s textbook can be purchased through Amazon and Barnes & Noble.

Discovering Last Month's Psoriasis Spotlight

The September 2023 issue of Dermatology Times featured a spotlight on psoriasis research, advances, and treatment options in patients with skin of color. Learn more about the topics covered in each spotlight article.

Stefan Weiss, MD, Discusses OM1’s New HS Dataset and Expanded Dermatology Network

The addition of an HS dataset adds approximately 26,000 new patient records.

SARS-CoV-2 Associated With Increased Incidence of Psoriasis

In a cohort of patients in the UK, investigators found that SARS-CoV-2 was associated with increased incidence of several immune-mediated inflammatory diseases, with psoriasis among them.

Larry Eichenfield, MD, Addresses Pediatric AD, Upcoming Therapies, and Misinformation From Social Media

As cold weather is approaching for much of the country, it is crucial for dermatologists, pediatricians, and families to work together for proper pediatric atopic dermatitis care.

Real-World Insights: Systemic Therapies in Moderate to Severe Atopic Dermatitis Patients

These insights highlight the crucial role of systemic therapies in the comprehensive management of moderate to severe atopic dermatitis.

Addressing Disparities in Atopic Dermatitis Education on TikTok

Non-physician posts accumulated more than 3 times the number of views compared to those created by physicians. Among physicians, dermatologists demonstrated higher average view counts compared to non-dermatologists.

Utilizing Naturally Occurring Compounds for Treatment of Coexisting Vitiligo and Psychiatric Conditions

Vitiligo and psychiatric disorders share a strong connection, with up to 90% of vitiligo patients having comorbid psychiatric conditions.

Oxidative Damage Induces Increase of Pro-Inflammatory IL-15 in Vitiligo

Investigators evaluated the most important markers associated with the pathogenesis of vitiligo, including serum inflammatory and oxidative stress markers.

Pointers With Portela: Careers With an Increased Skin Cancer Risk

In this week’s Pointers With Portela, the 208SkinDoc explains why individuals with certain careers have an increased risk of developing skin cancer.

Genital Skin Cancers and Lichen Sclerosus

Many studies have investigated the associations between lichen sclerosus and vulvar and penile SCCs, as well as genital melanomas.

SLIDESHOW: Highlights From Maui Derm NP+PA Fall 2023

Discover the top pearls and takeaways from sessions at Maui Derm NP+PA Fall 2023 in Asheville, North Carolina.

High Proportion of Patients With Vitiligo in the US Do Not Receive Treatment, Study Says

A real-world retrospective analysis also found that among patients receiving treatment, most were unlikely to use more than 1 treatment or switch to an alternative treatment during the first year of diagnosis.

FDA Designates ABRILADA as Interchangable Humira Biosimilar

The designation now applies to all approved indications, which includes dermatologic conditions such as psoriatic arthritis, plaque psoriasis, and hidradenitis suppurativa.

The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium

Colleen Cotton, MD, discusses the treatment landscape of pediatric atopic dermatitis, highlights from her session at Maui Derm NP+PA in Asheville, NC, and more.

POLL: Do You Treat More Adult Women With Acne Than Men?

Click here to answer this week's acne poll.

Jonathan Silverberg, MD, Previews Upcoming Virtual RAD Conference and Exciting Topics

This year’s virtual atopic dermatitis conference takes place on Sunday, December 10, 2023.

Anti-Cancer Immunotherapy Treatments Spark Common Skin-Related Toxicities

Dermatologist Laura Ferris, MD, PhD, discusses skin-related toxicities as a result of immunotherapies for the treatment and management of cancers.

Picking Me Foundation Founder and CEO Discusses Significance of Dermatillomania Awareness in Dermatology

This Body-Focused Repetitive Behaviors Awareness Week, Dermatology Times is spotlighting the role of the only donor-supported nonprofit organization for dermatillomania in spreading awareness and education of skin picking.

FDA Approves Roflumilast Cream 0.3% In Children 6 to 11 Years With PsO

The approval provides pediatric patients with a steroid-free topical therapy.

Path to Care Study Shows Significant Cost Consideration Disparities Among Cosmetic Dermatology Patients

Greg Pierce of Synchrony discusses CareCredit's Path to Care study and its findings related to cost and finance considerations for cosmetic dermatology patients.

Hands-On BCC Approach

Surgical removal techniques including Mohs surgery and excisional surgery are preferred treatment approach when addressing BCCs, particularly on the hands.

Eczema Lesion Detection Increased With EczemaNet2 Automated Assessment

Compared with the previous EczemaNet1, EczemaNet2 was more accurate in its automated detection of atopic dermatitis lesions.

Unmasking the Dermatologic Impact of Costume Makeup

Dermatology physician assistant Renata Block, MMS, PA-C, discusses pearls and best practices for patients ahead of October and Halloween festivities.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.